Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

Clinical trial NCT05445921 · COMPLETED

Trial details

NCT number: NCT05445921
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anosmia Hyposmia Parosmia Olfactory Disorder

Start date: 2022-09-01
Primary completion: 2022-12-12
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.